Similar Papers

Paper Title
Journal
Date
Author
Clinical Safety and Efficacy of Nilotinib or Dasatinib in Patients With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia and Pre-Existing Liver and/or Renal Dysfunction.
Koji Sasaki ... Gautam Borthakur
Clinical Lymphoma Myeloma and Leukemia | VOL. 16
Koji Sasaki, et. al.Koji Sasaki ... Gautam Borthakur
18 Dec 2015
Clinical Safety and Efficacy Of Nilotinib Or Dasatinib In Patients (Pts) With Newly Diagnosed Chronic-Phase Chronic Myelogenous Leukemia (CML-CP) With Pre-Existing Liver and/Or Renal Dysfunction
Koji Sasaki ... Jorge E Cortes
Blood | VOL. 122
Koji Sasaki, et. al.Koji Sasaki ... Jorge E Cortes
15 Nov 2013
Imatinib front‐line therapy is safe and effective in patients with chronic myelogenous leukemia with pre‐existing liver and/or renal dysfunction
Wei‐Gang Tong ... Hagop Kantarjian
Cancer | VOL. 116
Wei‐Gang Tong, et. al.Wei‐Gang Tong ... Hagop Kantarjian
07 Apr 2010
Imatinib Frontline Therapy Is Safe and Effective in Patients with Chronic Myeloid Leukemia (CML) with Liver and/or Renal Dysfunction.
Weigang Tong ... Jorge Cortes
Blood | VOL. 112
Weigang Tong, et. al.Weigang Tong ... Jorge Cortes
16 Nov 2008
View more papers

More From: Clinical Lymphoma Myeloma and Leukemia

Paper Title
Journal
Date
Author
Outcomes with Allogeneic Hematopoietic Stem Cell Transplantation in Therapy Related Myeloid Neoplasms: A Systematic Review and Meta-Analysis
Moazzam Shahzad ... Muhammad Umair Mushtaq
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Moazzam Shahzad, et. al.Moazzam Shahzad ... Muhammad Umair Mushtaq
01 Jan 2025
Effect of TKI maintenance therapy after allogeneic hematopoietic stem cell transplantation on recurrence of Philadelphia chromosome-positive acute lymphoblastic leukemia p190 and p210 transcripts - a multicentre study
Jiayi Zhen ... Ganlin He
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Jiayi Zhen, et. al.Jiayi Zhen ... Ganlin He
01 Jan 2025
Disease characteristics and treatment outcomes of Myeloma patients under 50 years of age: an analysis of the Balkan Myeloma Study Group
Despina Fotiou ... Efstathios Kastritis
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Despina Fotiou, et. al.Despina Fotiou ... Efstathios Kastritis
01 Jan 2025
Inotuzumab Ozogamicin as First-Line Therapy in Acute Lymphoblastic Leukemia
Elias J Jabbour ... Matthias Stelljes
Clinical Lymphoma Myeloma and Leukemia | VOL. -
Elias J Jabbour, et. al.Elias J Jabbour ... Matthias Stelljes
01 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.